CLVT — Clarivate Plc

Clarivate (CLVT) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $586 million, reflecting a 1.6% organic ACV growth, with subscription organic revenue growth at 1.7%.
• Adjusted EBITDA: $241 million, representing a 41% margin, up nearly 200 basis points year-over-year.
• Net Loss: $40 million, an improvement of $64 million from the prior year, attributed to foreign exchange benefits and lower restructuring costs.
• Adjusted Diluted EPS: Increased by nearly 30% to $0.18.
• Free Cash Flow: Approximately $79 million, allowing for $143 million in debt retirement during the quarter.

2. Strategic Updates and Business Highlights

• Value Creation Plan: Progressing well with a focus on business model optimization, improved sales execution, AI innovation, and portfolio rationalization.
• Subscription Adoption: Over 600 new subscriptions sold in the last 12 months, reinforcing the shift towards subscription-based offerings.
• AI Initiatives: Significant investments in AI leading to operational efficiencies and enhanced product offerings, including collaborations with Anthropic for AI integration.
• Geographic Expansion: Strong growth in the China market, particularly in the Academia & Government segment, with multiple new subscriptions secured.
• Intellectual Property (IP) Segment: Improvement in renewal rates and sales execution, with expectations for future growth driven by AI innovations.

3. Forward Guidance and Outlook

• Full Year Guidance: Reaffirmed with expectations for organic ACV growth of 2-3% and recurring organic growth of approximately 1.5%.
• Revenue Expectations: Anticipated decline of about $100 million due to business disposals, with total revenue projected at $2.36 billion.
• Adjusted EBITDA Margin: Expected to grow to nearly 43% at the midpoint of the range.
• Free Cash Flow: Projected to grow by about 10% to $400 million.

4. Bad News, Challenges, or Points of Concern

• Transactional Revenue Decline: Noted decrease in transactional revenues, primarily due to lower activity in the Academia & Government segment.
• IP Segment Challenges: While improvements are noted, the IP segment continues to operate in a muted environment, with expectations for a gradual recovery.
• Dependency on AI: While AI initiatives are promising, there is inherent risk in execution and competition as other firms also enhance their AI capabilities.

5. Notable Q&A Insights

• AI Product Traction: The company is seeing positive customer feedback on AI capabilities, with significant reductions in manual work reported by users.
• Competitive Landscape: Clarivate feels confident in its AI innovations and market position, despite competition also advancing in AI.
• China Market Potential: Strong momentum in China is noted, with expectations for continued growth in various segments, particularly ANG.
• Future of Life Sciences & Healthcare Segment: The segment is transitioning towards a higher subscription mix, which is expected to enhance predictability and growth over time.

Overall, Clarivate reported solid financial performance in Q1 2026, with strategic initiatives yielding positive results, though challenges remain in certain segments and overall market conditions.